Jun Zhang, MD, PhD, is a physician-scientist, principal investigator, and board-certified internist and medical oncologist. Dr. Zhang earned his medical degree from Xiang-Ya School of Medicine, Central South University in China, a PhD in Cancer Biology from LSU, completed a postdoctoral research fellowship at Harvard Medical School and UCSF, and a Hematology/Oncology fellowship at Emory University School of Medicine. Passionate about frontier scientific discoveries, Dr. Zhang possesses extensive expertise in bench-to-bedside translation and the development of investigator-initiated clinical trials. He has authored over 100 publications, including articles in high-impact journals such as Cancer Research, Clinical Cancer Research, Journal of Thoracic Oncology, Molecular Cancer, Annals of Oncology, JAMA Oncology, Cancer Cell, and New England Journal of Medicine. Dr. Zhang is a member of prestigious organizations, including AACR, ASCO, ESMO, IASLC, RSM, and CAHON, where he also served as the Committee Co-chair of Clinical Research.

His research interests encompass the following broad areas:
1) The role of microbiota in the oncogenesis, immune modulation, and immunotherapy of lung cancer.
2) Resistant mechanisms in targeted therapies for non-small cell lung cancer harboring driver mutations.
3) Development of innovative interventional and translational trials for various thoracic malignancies.

Currently, he serves as the co-Director of the Lung Cancer Program and Associate Director of the Early Phase Program at the University of Kansas Comprehensive Cancer Center (KUCC). Dr. Zhang plays a vital role in leading a multidisciplinary team in both research and patient care for Thoracic Oncology at KUCC.